NCT06554795 2026-03-19
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1/2 Recruiting
DualityBio Inc.
BioCytics, Inc.
Akeso
BioInvent International AB
CytomX Therapeutics
Grit Biotechnology
Corbus Pharmaceuticals Inc.
Accession Therapeutics Limited
Suzhou Abogen Biosciences Co., Ltd.
Egle Therapeutics
CytomX Therapeutics
Chengdu Baiyu Pharmaceutical Co., Ltd.
Effector Therapeutics
Telix Pharmaceuticals (Innovations) Pty Limited
Grit Biotechnology
Shanghai Huaota Biopharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co. Ltd